| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |